Latest DEF 14A proxy statements

Transcontinental Realty Investors, Inc. announces its Annual Meeting of Stockholders for December 10, 2025, to elect directors and ratify its independent accounting firm.

Leap Therapeutics, Inc. is seeking stockholder approval for proposals including an increase in authorized shares, a reverse stock split, a new equity incentive plan, and the potential issuance of over 19.99% of common stock upon warrant exercise.

CompoSecure, Inc. plans a strategic combination with Husky Technologies Limited, creating a diversified industrial compounder valued at approximately $7.36 billion.

CompoSecure, Inc. announced a proposed combination with Husky Technologies Limited, seeking shareholder approval for the issuance of shares to facilitate the transaction and related private placements.

InMed Pharmaceuticals Inc. announces its 2025 Annual General and Special Meeting to be held virtually on December 17, 2025, seeking shareholder approval for director elections, auditor appointment, and a significant share issuance under a standby equity purchase agreement.

Heidrick & Struggles International, Inc. stockholders are invited to a special meeting on December 5, 2025, to vote on a $59.00 per share all-cash merger agreement with affiliates of Advent International and Corvex PE Advisors.

Greenpro Capital Corp. announces its annual meeting on November 26, 2025, for informational purposes, with key corporate actions already approved by majority stockholder consent.

Guess?, Inc. announced that the Hart-Scott-Rodino antitrust waiting period for its merger with Authentic Brands Group LLC has expired, moving the company closer to becoming privately held.

International Endeavors Corp. announced a name change to ModuLink Inc. and an increase in authorized common stock from 4 billion to 6 billion shares, approved by its Board and majority stockholders.

Leap Therapeutics calls a special meeting to approve a significant share increase, a potential reverse stock split for Nasdaq compliance, and a new equity plan, following a $58.88 million private placement led by Winklevoss Capital.

InMed Pharmaceuticals Inc. announces its Annual General and Special Meeting on December 17, 2025, seeking shareholder approval for director elections, auditor reappointment, and a potential equity issuance of 20% or more of common shares.

BioCardia, Inc. announced its 2025 Annual Meeting of Stockholders will address the election of three Class III directors, an extension and amendment of its 2016 Equity Incentive Plan, and the ratification of its independent auditor.

Metsera, Inc. has issued a statement disagreeing with Pfizer's litigation allegations, vowing to address them in court.

Phunware, Inc. has filed definitive additional proxy materials related to its upcoming 2025 Annual General Meeting.

FG Nexus Inc. has filed a Definitive Proxy Statement with the U.S. Securities and Exchange Commission.

Workhorse Group Inc. is urging shareholders to vote in favor of its proposed merger with Motiv Power Systems, Inc. and all related proposals at its 2025 Annual Meeting to create long-term shareholder value in the medium-duty EV market.

NeoVolta, Inc. announced its 2025 Annual Meeting of Shareholders to be held on December 10, 2025, to vote on director elections and auditor ratification.

Tesla, Inc. has filed additional definitive proxy materials, including employee communications, Elon Musk's X posts, and website updates, related to its 2025 Annual Meeting of Shareholders.

The U.S. Department of Justice has issued a Second Request for additional information regarding the proposed merger between TEGNA Inc. and Nexstar Media Group, Inc., extending the regulatory review period.

Quantum Corporation announces its 2025 Annual Meeting of Shareholders to vote on director elections, convertible note exchanges, and an equity incentive plan amendment.

Wellgistics Health, Inc. announces the removal of two directors by majority shareholder consent and the appointment of four new directors, including a new President.

Stitch Fix, Inc. has filed a definitive additional materials proxy statement with the U.S. Securities and Exchange Commission.

WD-40 Company has filed a definitive proxy statement with the SEC, signaling upcoming shareholder matters.

Xenetic BioSciences, Inc. announced its 2024 Annual Meeting of Stockholders will be held virtually on December 11, 2024, to vote on director elections, auditor ratification, and executive compensation.

The Campbells Company issued a supplement to its 2025 proxy statement, clarifying director compensation oversight and defending Board Chair Keith R. McLoughlin's $350,000 annual retainer against an ISS recommendation.

Great Elm Group, Inc. filed an amendment to its 2025 Annual Stockholders Meeting proxy statement, updating committee compositions and proposing a new long-term incentive compensation plan.

Glucotrack, Inc. announced the adjournment of its Special Meeting of Stockholders from October 31, 2025, to November 7, 2025, with no changes to the record date or proposals.

Marwynn Holdings, Inc. announced its Annual Meeting of Stockholders for December 15, 2025, to elect directors and ratify its accounting firm.

Epsilon Energy Ltd. has filed a supplement to its definitive proxy statement for the upcoming special meeting to approve the acquisition of Peak Exploration & Production and Peak BLM Lease, addressing shareholder demands and complaints regarding disclosure.

Microsoft Corporation filed a supplement to its 2025 proxy statement, clarifying the exclusion of two shareholder proposals due to procedural non-compliance and the impact of a government shutdown on SEC no-action processes.